FLSM
Frazier Life Sciences Management Portfolio holdings
AUM
$2.5B
This Quarter Return
+25.98%
1 Year Return
+52.94%
3 Year Return
+530.54%
5 Year Return
–
10 Year Return
–
AUM
$1.67B
AUM Growth
+$293M
(+21%)
Cap. Flow
+$72.6M
Cap. Flow
% of AUM
4.33%
Top 10 Holdings %
Top 10 Hldgs %
66.82%
Holding
53
New
4
Increased
12
Reduced
8
Closed
5
Top Buys
| 1 |
Disc Medicine
IRON
|
$29.1M |
| 2 |
Phathom Pharmaceuticals
PHAT
|
$24.4M |
| 3 |
NewAmsterdam Pharma
NAMS
|
$18.2M |
| 4 |
Oric Pharmaceuticals
ORIC
|
$16.6M |
| 5 |
BridgeBio Pharma
BBIO
|
$14.1M |
Top Sells
| 1 |
Vaxcyte
PCVX
|
$11.6M |
| 2 |
VECT
VectivBio Holding AG Ordinary Shares
VECT
|
$11.6M |
| 3 |
Cogent Biosciences
COGT
|
$7.79M |
| 4 |
Avidity Biosciences
RNA
|
$7.68M |
| 5 |
Replimune Group
REPL
|
$6.97M |
Sector Composition
| 1 | Healthcare | 99.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Zymeworks
ZYME
$1.07B
| – | – |
-610,000
| Closed | -$5.51M |
|
|
VECT
52
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
| – | – |
-1,352,199
| Closed | -$11.6M |
|
|
NBRV
53
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| – | – |
-17,025
| Closed | -$29.7K |
|